7.1
La jonction neuromusculaire et blocage
Le site de communication chimique entre un neurone moteur et une fibre musculaire est appelé la jonction neuromusculaire (NMJ). L'extrémité du neurone…
La jonction neuromusculaire, ou NMJ, est un site de communication chimique entre un motoneurone et une fibre musculaire pour faciliter la contraction des muscles squelettiques. Les médicaments appelés bloqueurs neuromusculaires ciblent la JNM et aident à induire la paralysie musculaire.
La NMJ se compose de la terminaison nerveuse motrice et de la plaque motrice d'une fibre musculaire séparées par une petite fente synaptique. L’acétylcholine, un neurotransmetteur libéré par la terminaison nerveuse, agit comme un messager chimique entre les deux cellules.
Lorsqu’un potentiel d’action atteint l’extrémité neuronale, il déclenche la libération d’acétylcholine dans la fente synaptique. L’acétylcholine se lie aux récepteurs nicotiniques de la plaque motrice et ouvre des canaux ioniques pour permettre aux ions sodium de pénétrer dans la cellule.
L’afflux d’ions sodium dépolarise la membrane musculaire, propageant le potentiel d’action et provoquant une contraction musculaire.
En raison de leur similitude structurelle avec l’acétylcholine, les bloqueurs neuromusculaires peuvent se lier aux récepteurs nicotiniques et bloquer la transmission des impulsions.
Par exemple, la succinylcholine entre en compétition avec l’acétylcholine pour lier les récepteurs et inhiber son action. Un tel blocage neuromusculaire détend les muscles chez les patients sous sédation pendant la chirurgie.
View the full transcript and gain access to JoVE Core videos
Q1: What is the neuromuscular junction and what role does it play in muscle contraction?
The neuromuscular junction (NMJ) is a site of chemical communication between a motor neuron and muscle fiber that facilitates skeletal muscle contraction. It consists of the motor nerve terminal, synaptic cleft, and motor end plate. When an action potential reaches the nerve terminal, it triggers acetylcholine release into the synaptic cleft, enabling impulse transmission across the NMJ and initiating muscle contraction.
Q2: How does acetylcholine trigger muscle contraction at the neuromuscular junction?
Acetylcholine, released from synaptic vesicles, binds to nicotinic receptors on the motor end plate. Two acetylcholine molecules open sodium ion channels, allowing Na+ influx that depolarizes the muscle membrane. This depolarization propagates an action potential along the muscle fiber, triggering muscle contraction. Acetylcholinesterase then breaks down acetylcholine to terminate the signal.
Q3: What is the mechanism by which neuromuscular blockers induce muscle paralysis?
Neuromuscular blockers bind to nicotinic receptors on the motor end plate, blocking acetylcholine from attaching and preventing impulse transmission across the NMJ. Because of their structural similarity with acetylcholine, drugs like succinylcholine compete for receptor binding sites. This blockade prevents sodium influx and action potential propagation, resulting in muscle relaxation and temporary paralysis during surgery.
Q4: How do botulinum toxin and tubocurarine differ in blocking neuromuscular transmission?
Botulinum toxin prevents acetylcholine release by blocking exocytosis of synaptic vesicles at the nerve terminal. Tubocurarine and similar nondepolarizing blockers bind to acetylcholine receptors on the motor end plate, preventing acetylcholine attachment. Both agents block impulse transmission but act at different sites within the NMJ to prevent muscle contraction.
Q5: What role does calcium play in acetylcholine release at the neuromuscular junction?
When a nerve impulse arrives at the synaptic bulb, it opens calcium channels, allowing Ca2+ influx into the nerve terminal. This calcium influx stimulates exocytosis of synaptic vesicles, releasing acetylcholine into the synaptic cleft. Without calcium entry, acetylcholine cannot be released, preventing neuromuscular transmission and muscle contraction.
Q6: Why are neuromuscular blockers used during surgical procedures?
Neuromuscular blockers induce muscle relaxation and temporary paralysis by blocking impulse transmission at the NMJ, making them valuable during surgery. They prevent involuntary muscle movement, allowing surgeons better access and control during procedures. This pharmacological paralysis is reversible and essential for anesthesia management in operating rooms.
Q7: What structural features allow neuromuscular blockers to interfere with acetylcholine function?
Neuromuscular blockers possess structural similarity to acetylcholine, enabling them to bind to nicotinic receptors on the motor end plate. This structural mimicry allows them to compete with acetylcholine for receptor binding sites. By occupying these receptors, blockers prevent acetylcholine attachment and subsequent ion channel opening, effectively halting neuromuscular transmission.